GSK appoints Sir Philip Hampton chair
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has officially announced that Sir Philip Hampton, currently chair of the Royal Bank of Scotland, will become chair of GSK following the departure of current chair Sir Christopher Gent.